Patents, Bio Rad Laboratories Inc, 10x Genomics, Microfluidics, Single Cell Sequencing.
large corporations such as Bio-Rad. Two of QuantaLife’s founders left Bio-Rad about a year after the acquisition, starting 10X Genomics. At the beginning, 10X avoided using droplet-based technology but with little success. Eventually, they picked up something familiar, i.e. droplets, to develop an